Targacept to cut more jobs after ADHD trial failure
TC-5619 disappoints in phase II trial after missing primary endpoint
Read More
Section: Research
Dutch biotech Mucosis promotes Thomas Johnston to CEO
He succeeds Govert Schouten who leaves to found an internet start-up
Read More
Merck withdraws EU filing for Erbitux in lung cancer
Follows request from EMA for more data
Read More
Pfizer’s RA drug tofacitinib tops methotrexate in phase III
Trial results back drug as major new treatment in rheumatoid arthritis
Read MoreINC Research expands Asian presence with South Korea facility
New Seoul office will focus on study start-up and clinical operations
Read More